🇺🇸 FDA

Intelligence Platform

Patents

Browse 302 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6462222

Aminoindan derivatives

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 08 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6452054

Sertraline hydrochloride polymorphs, processes for preparing them, compositions containing

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Sep 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6376545

Dispersible compositions containing L-DOPA ethyl ester

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 23 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6365574

Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions there

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 02 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6316504

Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6303650

Aminoindan derivatives

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 16 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6281381

Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 28 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6277886

Pharmaceutical compositions comprising S-(-)-N-propargyl-1-aminoindan

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 21 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6271263

Compositions containing and methods of using 1-aminoindan and derivatives thereof and proc

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 07 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6248888

Process for the preparation of terazosin hydrochloride dihydrate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 19 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6218566

Process for manufacturing of L-DOPA ethyl ester

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Apr 17 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6201148

Process for preparing alendronic acid

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 13 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6127426

10-substituted 1,8-dihydroxy-9 (10H) anthracenone pharmaceuticals

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 03 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6126968

Stable compositions containing N-propargyl-1-aminoindan

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 03 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired